According to the Discounted Future Cash flow calculation, the price is fairly (almost 40%) below intrinsic value, After achieving approval all these DFC calculation will be impacted by the strong response from the European market, we don't need to be magician to predict what is going to happen to this Beautiful, for more information, refer to the CEO interview by the famous The Australian commentator at eurekareport, disallowed link/investment-news/starpharma-prepares-to-launch-covid-killing-nasal-spray/149289
SPL Price at posting:
$1.88 Sentiment: None Disclosure: Not Held
